載入...
Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset decades of clinical practice?
In the early stage of the COVID-19 pandemic, Belgian health authorities endorsed the interim guidelines for the treatment of COVID-19 pneumonia: hydroxychloroquine (HCQ) recommended for treatment of hospitalized patients with moderate to severe disease. As a growing number of patients were admitted,...
Na minha lista:
| 發表在: | Clin Rheumatol |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer International Publishing
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7810282/ https://ncbi.nlm.nih.gov/pubmed/33452660 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10067-020-05572-9 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|